financetom
Business
financetom
/
Business
/
What's Going On With Tilray Brands Stock Today?
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
What's Going On With Tilray Brands Stock Today?
Mar 27, 2025 7:41 AM

Tilray Brands, Inc. ( TLRY ) and its subsidiary HEXO Corporation announced on Thursday the successful dismissal of a lawsuit filed by Clement Italume.

The company’s shares are trading slightly higher in the morning session following the announcement.

The Massachusetts Superior Court, Suffolk County, granted Tilray and HEXO’s motion for summary judgment, dismissing Italume’s claims.

The lawsuit, which sought approximately $8 million in damages, alleged that HEXO and Tilray failed to adequately notify shareholders about HEXO’s corporate actions in December 2022 and Tilray’s acquisition of HEXO in June 2023.

The plaintiff also claimed that a reverse stock split was improperly executed to “delete” or convert his HEXO shares.

Also Read: Shiba Inu Burn Rate Skyrockets 57,069%, But Why Did This Whale Burn 1M SHIB?

The court rejected these allegations, finding no substantial evidence that the corporate actions caused any financial loss to shareholders or that the companies failed to properly inform investors.

The ruling also noted that the plaintiff could not establish credible damages arising from his claims. It remains uncertain whether Italume will appeal the decision.

According to Benzinga Pro, TLRY stock has lost over 73% in the past year. Investors can gain exposure to the stock via AdvisorShares Pure Cannabis ETF ( YOLO ) .

Also, Tilray is bolstering its presence in the U.S. retail market through a strengthened partnership with Whole Foods Market.

The company is bringing back its HiBall Energy brand, which offers zero-calorie, sugar-free energy drinks, to retail shelves this spring.

HiBall Sparkling Energy Seltzer Waters is marketed as a healthier alternative to conventional energy drinks. This move aligns with Tilray’s strategy to expand its wellness offerings as it continues to diversify its portfolio.

Price Action: TLRY shares are trading higher by 3.4% to $0.6775 at last check Thursday.

Read Next:

GameStop Follows MSTR’s Footsteps: Why Will Investors Buy Convertible Notes With No Interest?

Image via Shutterstock.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Enlight Secures $340 Million in Tax Equity Partnerships for Arizona Project; Shares Up Pre-Bell
Enlight Secures $340 Million in Tax Equity Partnerships for Arizona Project; Shares Up Pre-Bell
Sep 29, 2025
07:46 AM EDT, 09/29/2025 (MT Newswires) -- Enlight Renewable Energy ( ENLT ) said Monday its Clenera unit closed two tax equity partnership agreements for the Roadrunner solar and energy storage project near Tucson, Arizona. The first agreement is with JPMorgan Chase's ( JPM ) J.P. Morgan Chase Bank and covers the project's 290-megawatt solar component. The second agreement is...
Form 8.3 - Dalata Hotel Group plc
Form 8.3 - Dalata Hotel Group plc
Sep 29, 2025
LONDON--(BUSINESS WIRE)--   Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed,...
Ingredion Agrees to Sell Majority Ownership in Rafhan Maize to Nishat Hotels and Properties in Pakistan
Ingredion Agrees to Sell Majority Ownership in Rafhan Maize to Nishat Hotels and Properties in Pakistan
Sep 29, 2025
07:44 AM EDT, 09/29/2025 (MT Newswires) -- Ingredion ( INGR ) said Monday it has signed a conditional deal to sell a 51% stake in Rafhan Maize to Nishat Hotels and Properties in Lahore, Pakistan. Financial terms were not disclosed. The food ingredients company will maintain a 20% stake in Rafhan, Ingredion ( INGR ) said, adding that it intends...
Applied Therapeutics Says Path Forward Not Determined for Govorestat; Shares Fall Pre-Bell
Applied Therapeutics Says Path Forward Not Determined for Govorestat; Shares Fall Pre-Bell
Sep 29, 2025
07:43 AM EDT, 09/29/2025 (MT Newswires) -- Applied Therapeutics ( APLT ) said Monday that a path forward for its new drug application for govorestat to treat Charcot-Marie-Tooth Sorbitol Dehydrogenase deficiency has not been determined. The company said it completed a meeting with the US Food and Drug Administration to discuss the potential submission in Q3. Applied Therapeutics ( APLT...
Copyright 2023-2026 - www.financetom.com All Rights Reserved